Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 1
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
U.S. NeuroSurgical Holdings, Inc., through its subsidiaries, owns and operates stereotactic radiosurgery centers that utilize gamma knife technology. The gamma knife is a stereotactic radio surgical device used to treat brain tumors and other malformations of the brain without invasive surgery. U.S. NeuroSurgical Holdings, Inc. was founded in 1993 and is based in Rockville, Maryland.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, r
Data is available to registered users only
Buy
Sell